Allogeneic bone marrow mesenchymal stem cells transplantation for stabilizing and repairing of atherosclerotic ruptured plaque

Thrombosis Research

Volumn 131, Issue 6, 2013, Pages

  Fang, Shun Miao ^a   Du, Da Yong ^b   Li, Yun Tian ^b   Ge, Xing Li ^a   Qin, Peng Tao ^a   Zhang, Qing Hua ^b   Liu, Yang ^b  

^a XI'AN MEDICAL UNIVERSITY   (China)

^b The 305 Hospital of the People's Liberation Army   (China)

Author keywords

atherosclerosis; bone marrow mesenchymal stem cells; ruptured plaque; transplantation

Indexed keywords

C REACTIVE PROTEIN; COLLAGEN FIBER; GELATINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROTIC PLAQUE RUPTURE; BONE MARROW MESENCHYMAL STEM CELL TRANSPLANTATION; CELL COUNT; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL RABBIT; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RUPTURE; TREATMENT OUTCOME;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; C-REACTIVE PROTEIN; LIPIDS; MALE; MATRIX METALLOPROTEINASE 9; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PLAQUE, ATHEROSCLEROTIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; RABBITS; TRANSPLANTATION, HOMOLOGOUS;

EID: 84878886191     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.04.002     Document Type: Article

References (22)

1. T. Ohtani, Y. Ueda, I. Mizote, J. Oyabu, K. Okada, and A. Hirayama Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy J Am Coll Cardiol 47 2006 2194 2200
2. G.W. van Lammeren, B.L. Reichmann, F.L. Moll, M.L. Bots, D.P. de Kleijn, and J.P. de Vries Atherosclerotic plaque vulnerability as an explanation for the increased risk of stroke in elderly undergoing carotid artery stenting Stroke 42 2011 2550 2555
3. P.S. Mullenix, S.J. Huddleston, A. Stojadinovic, G.D. Trachiotis, and E.P. Alexander A new heart: somatic stem cells and myocardial regeneration J Surg Oncol 105 2012 475 480
4. J.G. Shake, P.J. Gruber, W.A. Baumgartner, G. Senechal, J. Meyers, and J.M. Redmond Mesenchymal stem cell implantation in a swine myocardial infarct model: engraftment and functional effects Ann Thorac Surg 73 2002 1919 1925
5. S. Tomita, D.A. Mickle, R.D. Weisel, Z.Q. Jia, L.C. Tumiati, and Y. Allidina Improved heart function with myogenesis and angiogenesis after autologous porcine bone marrow stromal cell transplantation J Thorac Cardiovasc Surg 123 2002 1132 1140
6. K. Neef, Y.H. Choi, A. Weichel, P.B. Rahmanian, O.J. Liakopoulos, and C. Stamm The influence of cardiovascular risk factors on bone marrow mesenchymal stromal cell fitness Cytotherapy 14 2012 670 678
7. S.M. Fang, Q.H. Zhang, and Z.X. Jiang Developing a novel rabbit model of atherosclerotic plaque rupture and thrombosis by cold-induced endothelial injury 16 2009 39 10.1186/1423-0127-16-39
8. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, and J.D. Mosca Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
9. R. Abbate, G. Cioni, I. Ricci, M. Miranda, and A.M. Gori Thrombosis and Acute coronary syndrome Thromb Res 129 2012 235 240
10. M.K. Reriani, A.J. Flammer, A. Jama, L.O. Lerman, and A. Lerman Novel functional risk factors for the prediction of cardiovascular events in vulnerable patients following acute coronary syndrome Circ J 76 2012 778 783
11. V. Panichi, A. Scatena, M. Migliori, V. Marchetti, S. Paoletti, and S. Beati Biomarkers of chronic inflammatory state in uremia and cardiovascular disease Int J Inflamm 2012 2012 360147
12. G. Laskarin, L. Zaputovic, V. Persic, A. Ruzic, and V. Sotosek Tokmadzic Harmful immune reactions during acute myocardial infarction Med Hypotheses 78 2012 703 706
13. M.A. Albert, R.J. Glynn, and P.M. Ridker Plasma concentration of C- reactive protein and the calculated Framingham coronary heart disease risk score Circulation 108 2003 161 165
14. L. Forte, G. Cimmino, F. Loffredo, R. De Palma, G. Abbate, and P. Calabrò C-reactive protein is released in the coronary circulation and causes endothelial dysfunction in patients with acute coronary syndromes Int J Cardiol 152 2011 7 12
15. A. Kułach, J. Da̧bek, J. Głogowska-Ligus, W. Garczorz, and Z. Ga̧sior Effects of standard treatment on the dynamics of matrix metalloproteinases gene expression in patients with acute coronary syndromes Pharmacol Rep 62 2010 1108 1116
16. F. Haverkate Levels of haemostatic factors, atherosclerosis and cardiovascular disease Vascul Pharmacol 39 2002 109 112
17. J. Guo, G.S. Lin, C.Y. Bao, Z.M. Hu, and M.Y. Hu Anti-inflammation role for mesenchymal stem cells transplantation in myocardial infarction Inflammation 30 2007 97 104
18. N. Werner, S. Junk, U. Laufs, A. Link, K. Walenta, and M. Bohm Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury Circ Res 93 2 2003 e17 e24
19. Y. Jiang, B.N. Jahagirdar, R.L. Reinhardt, R.E. Schwartz, C.D. Keene, and X.R. Ortiz-Gonzalez Pluripotency of mesenchymal stem cells derived from adult marrow Nature 418 2002 41 49
20. S. Schu, M. Nosov, L. O'Flynn, G. Shaw, O. Treacy, and F. Barry Immunogenicity of allogeneic mesenchymal stem cells. Immunogenicity of allogeneic mesenchymal stem cells J Cell Mol Med 2011 10.1111/j.1582-4934
21. A. Gebler, O. Zabel, and B. Seliger The immunomodulatory capacity of mesenchymal stem cells Trends Mol Med 18 2012 128 134
22. W.T. Tse, J.D. Pendleton, W.M. Beyer, M.C. Egalka, and E.C. Guinan Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation Transplantation 75 2003 389 397